Skip to main content
. 2022 Mar 16;115(6):1501–1510. doi: 10.1093/ajcn/nqac056

FIGURE 2.

FIGURE 2

HRs and 95% CIs1 for the primary and secondary cancer outcomes, according to randomized assignment, in intention-to-treat analyses. 1Summary statistics were from Cox regression models that stratified baseline hazard functions by cocoa extract trial randomization group, age, sex, and recruitment cohort. Analyses were not adjusted for multiple comparisons. 2This outcome was a composite of invasive cancers of any site other than nonmelanoma skin cancer.